Ministry of Health
and Family Welfare
Maharashtra, Punjab, Karnataka,
Over 4.5 cr vaccine doses administered across the country
Cumulative Fatality Rate dips to 1.37%
Posted On: 22 MAR
2021 11:12AM by PIB
Maharashtra,
Punjab, Karnataka,
46,951 new cases were registered in
the last 24 hours. Of these, 84.49% are reported
from 6 States of Maharashtra, Punjab, Kerala, Karnataka,
Eight states, as outlined under, are displaying an upward
trajectory in the daily new COVID19 cases.
The graph below shows the total tests conducted and the
respective cumulative positivity rates of the eight focus states.
The Daily Positivity Rate (7-day average) currently stands at 3.70%.
Eight States/UTs have a weekly positivity rate more than the
national average.
On the other hand, the total vaccination coverage in
More than 4.50 cr (4,50,65,998) vaccine doses have been
administered through 7,33,597 sessions, as per the provisional report till 7 am
today. These include 77,86,205 HCWs (1st dose), 48,81,954 HCWs
(2nd dose), 80,95,711 FLWs (1st dose) and 26,09,742 FLWs (2nd Dose), 37,21,455 beneficiaries
aged more than 45 years with specific co-morbidities and 1,79,70,931 beneficiaries
aged more than 60 years have also received the 1st Dose.
HCWs |
FLWs |
45
to <60 years with Co-morbidities |
Over
60 years |
Total |
||
1st Dose |
2nd Dose |
1st Dose |
2nd Dose |
1st Dose |
1st Dose |
|
77,86,205 |
48,81,954 |
80,95,711 |
26,09,742 |
37,21,455 |
1,79,70,931 |
4,50,65,998 |
As on Day-65 of the vaccination drive (21st March, 2021), total 4,62,157 vaccine doses were given. As it was a Sunday, many States and UTs did not schedule vaccination sessions.
Out of which, 4,49,115 beneficiaries were vaccinated across
8,459 sessions for 1st dose (HCWs
and FLWs) and 13,042 HCWs and FLWs received 2nd dose of vaccine.
Date:
21st March,2021 |
|||||||
HCWs |
FLWs |
45
to < 60 years with Co-morbidities |
Over
60 years |
Total
Achievement |
|||
1stDose |
2ndDose |
1stDose |
2nd Dose |
1stDose |
1stDose |
1stDose |
2ndDose |
6,220 |
4,598 |
11,400 |
8,444 |
87,982 |
3,43,513 |
4,49,115 |
13,042 |
21,180 recoveries
were registered in the last 24 hours.
On the other hand, 212 deaths were reported in the last 24
hours.
Six
States account for 85.85%of the new
deaths.
The
Case Fatality Rate currently stands at 1.37% and is continuously declining.
Fourteen States/UTs have not reported any
COVID19 deaths in the last 24 hours. These are
****
MV/SJ
HFW/COVID States data/22ndMarch2021/1
(Release ID: 1706531) Visitor Counter : 974
Ministry of Health
and Family Welfare
Centre writes to States/UTs to Increase the Interval
between two doses of COVISHIELD to 4-8 weeks based on NTAGI and NEGVAC
Recommendation
Protection enhanced if the second dose of COVISHIELD is administered between
6-8 weeks
Posted On: 22 MAR
2021 3:20PM by PIB
In
view of the emerging scientific evidence, the interval between two doses of a
specific COVID-19 vaccine i.e. COVISHIELD, has been revisited by National
Technical Advisory Group on Immunization (NTAGI) and subsequently by National
Expert Group on Vaccine Administration for COVID-19 (NEGVAC) in its 20th
meeting. During this meeting the recommendation has been revised to provide 2nd
dose of COVISHIELD at 4-8 weeks’ interval after the 1st dose, instead of
earlier practiced interval of 4-6 weeks. This decision of revised time interval
between two doses is applicable ONLY to COVISHIELD and NOT to COVAXIN Vaccine.
In
a letter written by the Union Health Secretary Shri Rajesh Bhushan to the Chief
Secretaries of States/UTs today, he has noted that the Ministry of Health and
Family Welfare, Government of India has accepted the recommendations of NTAGI
and NEGVAC and has thereafter advised the States and UTs to ensure the
administration of 2nd dose of COVISHIELD to beneficiaries within this
stipulated time interval of 4-8 weeks after 1st dose.
Keeping
the existing scientific evidence in view, it appears that protection is
enhanced if the second dose of COVISHIELD is administered between 6-8 weeks,
but not later than stipulated period of 8 weeks. The Union Health Secretary has
urged the States and UTs to instruct the concerned officials accordingly to
undertake necessary steps to widely disseminate the message of revised dosing
interval amongst programme managers, vaccinators and recipients of COVISHIELD
vaccine and ensure adherence of the revised dosing interval.
*****
MV/SJ
(Release ID: 1706597) Visitor Counter : 1969
No comments:
Post a Comment